Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    16735085 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Safety and Immunogenicity Study of Live Attenuated Indian Rotavirus Vaccine Candidate Strains 116E and I321 in Infants
Condition: Rotavirus Infections
Interventions: Biological: 116E AGMK;   Drug: I321;   Drug: Placebo
2 Unknown  Dose Escalation Study to Evaluate Oral Rotavirus Vaccine 116E Live Attenuated in Healthy Infants 8 to 20 Weeks Old
Condition: Diarrhea
Intervention: Biological: Oral Rotavirus Vaccine 116E Live Attenuated

Study has passed its completion date and status has not been verified in more than two years.